Literature DB >> 32506320

Diffuse follicular lymphoma variant with a typical diagnostic pattern and an unusually aggressive clinical presentation.

Fernando Martín-Moro1, Juan Marquet-Palomanes2, Miguel Piris-Villaespesa2, Javier Lopez-Jiménez2, Mónica García-Cosío3.   

Abstract

Diffuse follicular lymphoma (FL) variant is a rare condition that shows distinctive clinical, morphological, immunophenotypic, and molecular features that distinguish it from classical FL. Diffuse FL variant is characterized by a predominantly diffuse growth pattern, absence of the t (14;18) IGH/BCL2 translocation, CD23 expression, and presence of 1p36 deletion. Gene mutations involving STAT6 have been reported, with nuclear expression of STAT6 and phosphorylated STAT6 detected by immunohistochemistry. Patients frequently present with inguinal node involvement and low clinical stage. We describe the case of an 80-year-old female diagnosed with diffuse FL variant, presented with a classic diagnostic pattern and an unusual aggressive clinical onset.

Entities:  

Keywords:  Clinical hematology; Diffuse follicular lymphoma variant; Genetics; Immunophenotype; Morphology

Year:  2020        PMID: 32506320     DOI: 10.1007/s12185-020-02901-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  1 in total

1.  PARP14 is a novel target in STAT6 mutant follicular lymphoma.

Authors:  Michael Mentz; William Keay; Verena Passerini; Oliver Weigert; Carolin Dorothea Strobl; Martina Antoniolli; Louisa Adolph; Michael Heide; Axel Lechner; Sarah Haebe; Elisa Osterode; Robert Kridel; Christoph Ziegenhain; Lucas Esteban Wange; Johannes Adrian Hildebrand; Tanaya Shree; Elisabeth Silkenstedt; Annette M Staiger; German Ott; Heike Horn; Monika Szczepanowski; Julia Richter; Ronald Levy; Andreas Rosenwald; Wolfgang Enard; Ursula Zimber-Strobl; Michael von Bergwelt-Baildon; Wolfgang Hiddemann; Wolfram Klapper; Marc Schmidt-Supprian; Martina Rudelius; Deepak Bararia
Journal:  Leukemia       Date:  2022-07-18       Impact factor: 12.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.